Granata Bio: Valuation, Funding & Investors
Granata Bio is a biopharmaceutical company dedicated to advancing the global infertility medication market. The company focuses on developing innovative solutions to address infertility, aiming to enhance treatment options and improve outcomes for individuals seeking reproductive assistance.
Leadership & Board
- Current Number of Employees
- 20
- Current LinkedIn Followers
- 5,785
Latest Estimated Valuation
- Total Amount Raised
- $15M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $15M
- Latest Funding Round
- Series A
Employee Trend
Granata Bio had 20 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
20Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Granata Bio had 5,785 followers as of November 9, 2026. The number of followers increased by 45 (0.78%) week-over-week.
5,785Latest Followers Count
45(0.78%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 15, 2025 | Series A | $15.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Gedeon Richter | Series A |
| CooperSurgical | Series A |
| Amboy Street Ventures | Series A |
Similar Companies
A snapshot of private companies similar to Granata Bio, helping you discover and navigate related company profiles.
Related News and Analysis
